Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01838057 · ClinicalTrials.gov registry record
Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting
A clinical trial, sponsored by Pfizer.
- Terminated
- Registry status
- 103
- Enrollment target
NCT01838057 is a clinical trial that was terminated before completion, run by Pfizer. The registered enrollment target is 103 participants.
The verdict
NCT01838057 was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- 103 participants
- Enrollment target
Study Summary
To evaluate the impact of painPRIMER in a prospective six-month clinical investigation looking at clinical outcomes, health care professional and patient satisfaction, healthcare resource use, productivity and direct and indirect costs. The hypothesis is that early identification of the presence of neuropathic pain and back pain related comorbidities, to direct appropriate pharmacologic and non-pharmacologic treatment, painPRIMER would improve patient outcomes and reduce patient cycling, inappropriate use of imaging and surgery, thereby reducing costs and productivity loss associated with these inefficiencies.
Interventions
- OTHER Control cohort
- DEVICE painPREMIER cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01838057
The ClinicalTrials.gov registry entry for NCT01838057 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control cohort is the first listed.
NCT01838057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01838057 about?
NCT01838057 is a clinical study titled "Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting". To evaluate the impact of painPRIMER in a prospective six-month clinical investigation looking at clinical outcomes, health care professional and patient satisfaction, healthcare resource use, productivity and direct and indirect costs. The hypothesis is that early identification of the presence of ...
What is the current status of trial NCT01838057?
This trial is currently terminated. The enrollment target is 103 participants. The study started on 2013-06. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01838057?
The interventions under investigation include: Control cohort (OTHER), painPREMIER cohort (DEVICE).
Who is sponsoring clinical trial NCT01838057?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.